TWi Biotechnology, Inc(TW:6610)
NT$17.50-0.05 (-0.28%)
TW:6610
TWi Biotechnology, Inc financials statements
NT$17.50
At close:-0.05 (-0.28%)
TWi Biotechnology, Inc (6610) Income Statement
TWi Biotechnology, Inc Income Statement
Last quarter (Q2 2026), TWi Biotechnology, Inc's total revenue was NT$0.00. In Q2, TWi Biotechnology, Inc's net income was NT$-184.01M. See TWi Biotechnology, Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | NT$ 66.40M | |
| NT$ -35.32M | NT$ -9.70M | NT$ -9.74M | NT$ -10.35M | NT$ 65.48M | |
| NT$ 321.70M | NT$ 168.78M | NT$ 169.56M | NT$ 90.18M | NT$ 80.78M | |
| Depreciation and Amortization | NT$ 35.32M | NT$ 9.70M | NT$ 9.74M | NT$ 10.35M | NT$ 11.10M |
| NT$ -321.70M | NT$ -154.94M | NT$ -160.86M | NT$ -65.78M | NT$ -4.11M | |
| NT$ -357.02M | NT$ -178.49M | NT$ -169.56M | NT$ -90.18M | NT$ -15.30M | |
| NT$ -495.00K | NT$ 13.68M | NT$ -1.13M | NT$ 14.00M | NT$ 4.00K | |
| NT$ -357.52M | NT$ -164.81M | NT$ -170.68M | NT$ -76.18M | NT$ -15.30M | |
| NT$ -202.37M | NT$ -164.81M | NT$ -170.68M | NT$ -76.18M | NT$ -15.30M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.04 | NT$ -1.77 | NT$ -2.20 | NT$ -1.13 | NT$ -0.22 |
| Diluted EPS | NT$ -1.04 | NT$ -1.77 | NT$ -2.20 | NT$ -1.13 | NT$ -0.22 |
| Weighted Average Shares Outstanding | 194.01M | 92.96M | 77.62M | 67.43M | 70.22M |
| Weighted Average Shares Outstanding (Diluted) | 194.01M | 92.96M | 77.62M | 67.43M | 70.22M |
Currency in TWD

